Trump's executive order on drug pricing is generally received positively because lowering costs is a popular goal among voters across the political spectrum.

“in response to this, while there's been some criticism that the move doesn't go far enough or it's not the right kind of action, or that U.S. patients get quicker access to drugs because of the higher prices, the general reaction seems to be mostly positive.”